In this paper we compare the role of internal finance on the growth of firms between a leading transition country, Slovenia and an established market economy, Belgium. We find that firms in Slovenia are more sensitive to internal financing constraints than their Belgian counterparts. This would...

This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without...

This paper investigates the detfirminants of firm survival and growth in Slovenia, a country in transition from a plan to a market economy. firm growth (measured using employment) and firm survival (the probability of remaining in activity) are estimated using firm level data for the years 1994...

In most of the countries in transition from a planned to a market economy (firmer Soviet Union (FSU) and Central and Eastern Europe (CEE)) patients are routinely asked to pay unofficially for the medicines and other supplies that ought to be free. They are often described as 'payments to...